Study brain effects of a serotonin system drug in adults
This Phase 1 study tests how a serotonin-related drug changes brain activity in healthy adults, using brain imaging (MRI) and other measures. Because it involves a drug that may affect the brain, eligibility is designed to keep the results safe and clear.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult older than 18 years
- Have no history (and no close family history) of major psychiatric illness
- Have no major past or current nervous system or serious body illness, and avoid drugs that could affect results
- Be able to safely complete MRI (no MRI safety contraindications) and have normal vision/hearing ability
- Do not be pregnant or breastfeeding
- Avoid certain risks: alcohol or drug abuse, hallucinogenic drug use/allergy, abnormal heart rhythm tests or QT-prolonging medicines, and very low body weight
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how psilocybin (the active ingredient in magic mushrooms) affects consciousness by blocking a specific serotonin receptor in the brain. It helps researchers understand why psilocybin causes altered states of mind.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
This trial tests whether a combination of psilocybin and D-serine is safe and affects mood and thinking. It's for healthy people who want to help research on psychedelics.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
This study tests how psilocybin, a substance that can cause hallucinations, affects memory and brain activity in healthy adults. It may help us understand how psilocybin could be used for mental health treatments.
Hear when a new Basic Science trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.